Cigna Group — Director's Dealing 2025

Mar 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2025-02-28

Reporting Person: Jones Nicole S (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-28	Common Stock, $.01 Par Value	A	9064.0000	$0.0000	Acquired	36287.0000	Direct
2025-02-28	Common Stock, $.01 Par Value	A	3147.0000	$0.0000	Acquired	39434.0000	Direct
2025-02-28	Common Stock, $.01 Par Value	F	949.0000	$305.8600	Disposed	38485.0000	Direct
2025-02-28	Common Stock, $.01 Par Value	F	4160.0000	$305.8600	Disposed	34325.0000	Direct
2025-03-03	Common Stock, $.01 Par Value	S	4904.0000	$308.1200	Disposed	29421.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-28	Employee Stock Option (Right to Buy)	$305.8550	A	11176.0000	Acquired	2035-02-28	Common Stock, $.01 Par Value (11176.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.01 Par Value	1406.3086	Indirect

Footnotes

F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

F2: These restricted shares vest in three equal annual installments beginning March 1, 2026.

F3: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

F4: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

F5: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.

F6: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

F7: This option vests in three equal annual installments beginning March 1, 2026.